PBMs: Their Role, the Problems, and How Practices Can Work With Them

coapharm2017-10-30T15:06:31+00:00October 30, 2017|

CVS is Reportedly Considering Buying Health-Insurance Giant Aetna for $66 Billion

coapharm2017-10-27T18:27:48+00:00October 27, 2017|

Rapid flurry of new drug pricing leaves no room for public debate

coapharm2017-10-27T18:25:59+00:00October 27, 2017|

Advice for Pharmacists in Preparing for USP 800 Regulations

coapharm2017-10-25T14:22:53+00:00October 25, 2017|

U.S. Hospitals Wrestle With Shortages of Drug Supplies Made in Puerto Rico

coapharm2017-10-25T14:19:43+00:00October 25, 2017|

What Is Your Pharmaceutical Footprint?

coapharm2017-10-20T15:08:50+00:00October 20, 2017|

Cancer Drug Prices Rising Far Faster Than Inflation

coapharm2017-10-20T14:58:12+00:00October 20, 2017|

A Cancer Treatment That’s Part of ‘A Big New Field of Medicine’ Just Got Approved

coapharm2017-10-19T20:24:59+00:00October 19, 2017|

Amazon, Anthem, Congress Put Drug Benefits Firms in Hot Spot

coapharm2017-10-19T20:23:27+00:00October 19, 2017|

Does Site-of-Care for Oncology Infusion Therapy Influence Treatment Patterns, Cost, and Quality in the United States?

coapharm2017-10-19T20:22:12+00:00October 19, 2017|